
Dasafav 50 Tablet
Marketer
Aureate Healthcare Pvt Ltd
Salt Composition
Dasatinib (50mg)
Overview Dasafav 50 Tablet
Dasafav 50mg tablets treat chronic myeloid leukemia (blood cancer), specifically in patients unresponsive to, or intolerant of, other leukemia therapies. Administer this medication with or without food, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose can lead to severe complications. Therapeutic effects might not be apparent for several weeks or months; discontinue only under medical supervision. Common side effects include nausea, vomiting, stomach pain, and skin rashes. Increased heart rate, and low or high blood pressure are potential side effects requiring immediate medical attention; regular blood pressure monitoring may be necessary. Avoid antacids within two hours of taking this medication. This drug can lower blood cell counts, increasing infection risk, necessitating regular blood tests. Inform your healthcare provider about all medications you're taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding. Refrain from driving if dizziness or vision impairment occurs.
Primary Ingredients of Dasafav 50 Tablet
No text was provided to rewrite.
Uses of Dasafav 50 Tablet
Chronic myelogenous leukemia, a type of blood cancer
Major Benefits of Dasafav 50 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Dasafav 50 Tablet can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Dasafav 50 Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Dasafav 50 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dasafav 50 Tablet. Always swallow the tablet whole; avoid chewing, crushing, or breaking it. While Dasafav 50 Tablet can be ingested with or without food, maintaining a consistent administration time is recommended.
How Dasafav 50 Tablet works:
Dasafav 50mg tablets are a cancer treatment that inhibits the activity of a faulty protein responsible for cancer cell proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of consuming alcohol while taking Dasafav 50 Tablet is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Dasafav 50 Tablet during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Dasafav 50 Tablet are incompatible; evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Dasafav 50 Tablet may induce adverse reactions that could impair driving ability. Exercise caution while operating a vehicle if dizziness or blurred vision occurs after taking Dasafav 50 Tablet.
KidneySAFE IF PRESCRIBED
Dasafav 50 Tablet appears safe for use in individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Dasafav 50mg tablets pose no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Dasafav 50 Tablet :
Omit any missed Dasafav 50 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Dasafav 50 Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine and Thiazole Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Kinase inhibitors targeting tyrosine |
